KTTA
USDPasithea Therapeutics Corp. Common Stock
$0.690+0.010 (1.471%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.680
High
$0.710
Low
$0.650
Volume
0.08M
Company Fundamentals
Market Cap
5.1M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.13M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.65Current $0.690High $3.85
Related News
GlobeNewswire
Pasithea Therapeutics Announces Activation of Clinical Trial Site at University of Alabama at Birmingham for Ongoing Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ:KTTA) ("Pasithea" or the "Company"), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic oral MEK
View more
Related Stocks
OPTT
Ocean Power Technologies Inc.
NASDAQ
Electric Utilit...
HTD
John Hancock Tax Advantaged Dividend Income Fund Common Shares of Beneficial Interest
NASDAQ
Finance Compani...
GHIXU
Gores Holdings IX Inc. Unit
NASDAQ
Blank Checks
CTBI
Community Trust Bancorp Inc.
NASDAQ
Major Banks
VCSA
Vacasa Inc.
NASDAQ
Diversified Com...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.